Information about AstraZeneca: PharmaVitae Profile

18-Aug-2011 | News-Press Release

This analysis examines the historical and forecast performance for AstraZeneca in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. ( )
 Features and benefits - Gain insight into AstraZeneca's strategic outlook across the next 6 years. Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source. Highlights - Strategic insight into the prospects for AstraZeneca over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.
 Your key questions answered - Benchmark AstraZeneca's performance against key rivals in the prescription pharmaceutical sector. Assess the importance of Crestor, set to become the industry's biggest-selling product, to AstraZeneca's forecast growth performance. Analyse AstraZeneca's high level of anticipated exposure to flagship product patent expiries through to 2015 and the impact on company strategy
 For more information kindly visit :
 Related Reports
 Abbott Laboratories: PharmaVitae Profile 
 Mitsubishi Tanabe Pharma Corp.: PharmaVitae Profile 
 Contact us at :
 Bharat Book Bureau
 Tel: +91 22 27578668
 Fax: +91 22 27579131
 Follow us on twitter:!/BharatBook

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment